Status:
COMPLETED
Leptin and Ghrelin in ICU
Lead Sponsor:
özgür yağan
Conditions:
Critically Ill
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
Enteral alimentation is the preferred modality of support in critical patients who have acceptable digestive function and are unable to eat orally, but the advantages of continuous versus intermittent...
Eligibility Criteria
Inclusion
- who were unable to ingest an oral diet
- given decision on enteral feeding
Exclusion
- Carcinomatosis
- irreversible coma
- death or discharge before 14 days of observation
- contraindication to enteral feeding
- intolerance to the prescribed nutrients or infusion regimen
- burn
- multiple trauma
- morbid obesity
- end stage liver or renal or lung disease
- severe sepsis or septic shock
- patients with percutaneous endoscopic gastrostomy
- immunosuppressive drug use
- severe hemodynamic instability
- massive blood transfusion
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02282501
Start Date
August 1 2014
End Date
February 1 2016
Last Update
March 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital
Altinordu, Ordu, Turkey (Türkiye), 52100